Ronjon Nag

Ronjon Nag has over 20 years of experience in the technology industry. Ronjon is currently the Chairman at Ecrio, a leading provider of software solutions for mobile devices. Prior to joining Ecrio, Ronjon was the CEO of Celeris Therapeutics, a biopharmaceutical company focused on developing novel treatments for cardiovascular disease.

Ronjon's experience also includes executive roles at R42 Group, a technology incubator, and Stanford University. Ronjon has also served on the board of directors for several startups, including GTCardio, Bounce Imaging, and Payplant.

Ronjon Nag has a career in education that spans several different disciplines. Ronjon has a Bachelor of Science in Electronic and Electrical Engineering from the University of Birmingham, a PhD in Engineering from the University of Cambridge, and a Master of Science in Management Science from the MIT Sloan School of Management. Ronjon is also a Distinguished Careers Institute Interdisciplinary Fellow at the Center for the Study of Language and Information at Stanford University, and a Harkness Fellow in the Department of Psychology at Stanford University. In addition, they hold certifications from the ACM, the Engineering Council, the IEEE, the Institution of Engineering and Technology, and Coursera in Machine Learning.